Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
01/2004
01/27/2004US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/27/2004US6682855 Organometallic compound in solvent; electrochemical genertaors, supercapacitors
01/27/2004CA2214720C Arylsulfonylamino hydroxamic acid derivatives
01/27/2004CA2062387C Process for the preparation of sulfonylureas
01/22/2004WO2004007407A2 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
01/22/2004WO2004006829A2 Method of separating r(-)- and s(+)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl-2-methoxybenzene-sulphonamide
01/22/2004WO2003076391A3 Urokinase inhibitors, production and use thereof
01/22/2004WO2003024390A3 Hydroxyeicosenoic acid analogs
01/22/2004US20040014809 Novel n-( 2-phenyl-3-aminopropyl)naphtamides
01/22/2004US20040014758 Benzylcycloalkyl amines as modulators of chemokine receptor activity
01/22/2004CA2492270A1 Method of separating r(-)- and s(+)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl-2-methoxybenzene-sulphonamide
01/21/2004EP1382333A2 Use of beta 3 adrenergic receptor agonists in the treatment of dysuria
01/21/2004CN1469860A Aza-amino acid derivatives (factor XA-inhibitors 15)
01/21/2004CN1468850A Preparation of mono-N-sulfonicacid diamine
01/20/2004US6680317 N-(phenyl)-n*-(2-hydroxy-3-aminosulfonylphenyl)guanidine derivatives; chemokine inhibitors; respiratory, cardiovascular, rheumatic, brain, and nervous system disorders
01/15/2004WO2004005278A1 Bisarylsulfonamide compounds and their use in cancer therapy
01/15/2004WO2004004648A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
01/15/2004WO2003062191A8 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
01/15/2004US20040009982 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof
01/15/2004US20040009923 Alpha-substituted methyl ketones derived from aspartic acid and the closed hemi-ketal forms thereof
01/15/2004CA2491127A1 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
01/15/2004CA2488816A1 Bisarylsulfonamide compounds and their use in cancer therapy
01/14/2004EP1380571A1 Compounds useful for treating allergic and inflammatory diseases
01/14/2004EP1380562A1 Carboxylic acid derivative and salt thereof
01/14/2004EP1379517A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
01/14/2004EP1379508A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
01/14/2004EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
01/14/2004EP1379239A2 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
01/14/2004CN1468215A 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
01/14/2004CN1468214A Novel derivatives of aminocyclohexane
01/14/2004CN1468211A Nitroso diphenylamine derivatives
01/14/2004CN1468207A New retinoids for the treatment of emphysema
01/14/2004CN1134457C New alpha-aminoacetophenone photoinitiators
01/14/2004CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same
01/14/2004CN1134410C Amine derivative, process for producing same, and use thereof as antiarrhythmic medicine
01/14/2004CN1134383C Nitrification process
01/13/2004US6677488 Substituted biphenyl compounds for the treatment of inflammation
01/13/2004US6677487 Combining a tertiary amide with a pentavalent phosphorous halide in a solvent to form an alpha - haloiminium salt and converting the alpha -haloiminium salt to the alpha -haloenamine with a base
01/13/2004US6677472 As color-developing agent; high whiteness and resistance to color formation under high temperature
01/13/2004US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents
01/13/2004US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis
01/13/2004US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
01/13/2004US6677378 Monoamine reuptake inhibitors for treatment of CNS disorders
01/13/2004US6677376 Complexes comprising rotamase inhibitors and cyclophilins, administered for prevention of neurodegenarative diseases such as parkinson's or alzheimer's disease
01/13/2004US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/13/2004US6677367 Lysine derivative with 2-aminosulfonylthiophene substituent; acquired immunodeficiency syndrome (aids) viricides
01/13/2004US6677360 Biphenyl and biphenyl-analogous compounds as integrin antagonists
01/13/2004US6677355 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors
01/13/2004US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/13/2004US6677308 Integrin antagonists; antitumor, antimetastasis, anticarcinogenic agents; angiogenesis and restenosis inhibitors; osteoporosis
01/13/2004US6677277 Substituted sulphonyl amino(thio)carbonyl compounds and their use as herbicides
01/08/2004WO2004002944A1 Inhibitors of hcv ns5b polymerase
01/08/2004WO2004002941A1 Cosmetic or dermopharmaceutical compositions comprising tyramine derivatives, method for preparing same, and use thereof
01/08/2004WO2004002940A1 Inhibitors of hcv ns5b polymerase
01/08/2004WO2003077828A3 Novel florfenicol-type antibiotics
01/08/2004WO2003064378A3 Novel compounds that inhibit factor xa activity
01/08/2004US20040006245 For therapy of cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain
01/08/2004US20040006236 Diaminopropionic acid derivatives
01/08/2004US20040006130 For therapy of osteoporosis, hypoparathyreosis, osteosarcoma, periodontal disease, bone fracture, steoarthrosis, chronic rheumatoid arthritis, Paget's disease, humoral hypercalcemia, autosomal dominant hypocalcemia
01/08/2004US20040006050 Administering substituted phenylsulfonamide for therapy and prophylaxis of Alzheimer's Disease and Down's syndrome
01/08/2004CA2491156A1 Inhibitors of hcv ns5b polymerase
01/08/2004CA2490950A1 Inhibitors of hcv ns5b polymerase
01/07/2004EP1377543A1 Oxalic acid derivatives
01/07/2004EP1377542A1 Hiv protease inhibitors based on amino acid derivatives
01/07/2004EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
01/07/2004EP1377283A2 Compounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis
01/06/2004US6673817 Anticoagulants
01/06/2004US6673804 Preventing or treating arthritis (particularly osteoarthritis) or inhibiting metastasis, invasion or growth of cancer (particularly breast cancer)
01/02/2004EP1375478A1 Process for preparing amino compounds by using salen-manganese complexes as the catalyst
01/02/2004EP1375477A2 Process for preparing mono-N-sulfonylated diamines
01/02/2004EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
01/02/2004EP1373228A1 Substituted fluoroalcoxyphenylsulfonylurea
01/02/2004EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals
01/02/2004EP1373185A2 Hydrophobic polyamine analogs and methods for their use
01/02/2004EP1372632A1 Proliferative activator receptor (ppar) compounds
01/02/2004EP1372390A2 Alkylamine derivatives as antifouling agents
01/01/2004US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device
01/01/2004US20040002506 Antiproliferative agents; antitumor agents
01/01/2004US20040002493 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient
01/01/2004US20040002491 Melatonergic receptors
01/01/2004US20040002490 Melatonergic receptors
12/2003
12/31/2003WO2004001877A2 Electrolytes for electrooptic devices comprising ionic liquids
12/31/2003WO2004000798A1 N-sulphonylaminoacetonitriles having pesticidal properties
12/31/2003WO2004000797A1 Alpha-sulfonylamino-acetonitriles
12/31/2003WO2004000791A1 Benzene derivative
12/31/2003WO2004000781A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003WO2004000779A1 Process for producing phenyloxocarboxylic ester derivative
12/31/2003WO2004000762A2 Propionic acid derivatives and their use as hppars activators
12/31/2003WO2004000295A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/31/2003WO2004000215A2 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs
12/31/2003WO2003063576A3 Arylsulfonamidobenzylic compounds
12/31/2003CN1464875A Organometallic complexes, catalysts containing the same, and process for preparation of carboxylic esters
12/31/2003CN1132516C Amino-acetonitrile derivative, pesticides containing same for farm and gardening and use thereof
12/31/2003CA2491209A1 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003CA2490687A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/31/2003CA2490123A1 N-sulphonylaminoacetonitriles having pesticidal properties
12/31/2003CA2489359A1 Propionic acid derivatives and their use as hppars activators
12/30/2003US6670385 α-phenyl-βketosulfone
12/30/2003US6670376 Aryl aniline β2 adrenergic receptor agonists
12/30/2003US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 177